Lv1
50 积分 2024-10-10 加入
PD-1 inhibitor causes pathological injury to multiple organs in a Lewis lung cancer mouse model
5小时前
待确认
Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Study
1个月前
已完结
Clinical characteristics and severity of beta and delta variants of SARS-CoV-2 and the effect of vaccine on delta variants
1个月前
已完结
A meta-analysis to assess the risk of bleeding and thrombosis following chimeric antigen receptor T-cell therapy: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy
1个月前
已完结
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study
1个月前
已完结
Multiorgan Immune-Related Adverse Events During Treatment With Atezolizumab
1个月前
已完结
A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation–associated TMA
1个月前
已关闭
Immune-related adverse events of cancer immunotherapies targeting kinases
1个月前
已完结
A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation–associated TMA
1个月前
已关闭
A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation–associated TMA
1个月前
已关闭
皖公网安备34019202002308
